Weed.com > Articles > Medical Conditions > Neurological > Help for Epilepsy, Seizure Disorders
neuron header

Help for Epilepsy, Seizure Disorders

Medical Marijuana and Epilepsy & other Seizure Disorders

Using cannabis to treat epilepsy, seizure disorders, and other neurological conditions has actually been studied for a variety of years. It has actually been hotly disputed too.

Early evidence from lab studies, anecdotal reports, and little clinical research studies over a number of years recommend that cannabidiol (CBD) could potentially help control seizures. Research study on CBD has been tough to do and taken some time due to federal policies and minimal access to cannabidiol. There are also many financial and time constraints. In the last few years, a variety of studies have shown the benefit of specific plant-based CBD item in dealing with specific groups of individuals with epilepsy who have not reacted to standard therapies.

cannabis for epilepsy and seizure disorders

On June 25, 2018, the U.S. Food & Drug Administration (FDA) approved EPIDIOLEX ® (cannabidiol, CBD) oral solution for the treatment of seizures associated with 2 epilepsy syndromes – Lennox-Gastaut syndrome and Dravet syndrome – in people 2 years of age or older. Epidiolex represents a brand-new medication option for kids with these types of epilepsy. It is likewise the very first FDA approved medication to treat seizures in Dravet syndrome.

New Indication for Seizure Disorders:

The FDA recently approved a new indication for Epidolex in the treatment of epilepsy and seizure disorders. Here is the excerpt of that statement:

“The U.S. Food and Drug Administration approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with tuberous sclerosis complex (TSC) in patients one year of age and older. Epidiolex was previously approved for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DS). This is the only FDA-approved drug that contains a purified drug substance derived from cannabis. It is also the second FDA approval of a drug for the treatment of seizures associated with TSC.”

Read the full FDA release here:

FDA Approves New Indication for Drug Containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic Disease

Related:

Leave a Comment





Looking for Something?


Enjoy More!
Pardon the mess as we are just preparing to launch over the next few weeks and months as your source for THC, CBD etc.

Sign-up for early updates,
releases, & promotions.

By clicking "subscribe" you agree to receive emails from Weed.com and accept our terms of use, privacy and cookie policy.

Articles & Resources